Policy Analysis: Investment, Life Sciences, Policy
Horizon 2020 Special Coverage
The 2015 Science|Business Annual Summit
The Science|Business Annual Summit brings together leaders from research, industry and policy to debate current and future trends needed to unleash Europe’s technological potential.
- 17 November 2015
The future of manufacturing: Industry 4.0
A Science|Business public conference
Brussels - 01 October 2015
The Bioeconomy Challenge: Producing more from less
A Science|Business high-level roundtable
Brussels - 02 July 2015
The new European Commission: Bad news for research and innovation?
Advocates for cross-sectoral R&D support fear a downgrade in the new Commission – but in individual areas such as energy, digital technologies, and pharmaceuticals, a stronger emphasis on growth and investment is good news for many
Published:
The view from the US: Stem cell therapy steps up a gear with first approval and improved political climate

Positive clinical data, increases in federal funding and the first regulatory approval of a manufactured stem cell product mean momentum is building in the US. With the re-election of President Obama, this is likely to continue


Image: Bigstock

When US President Barack Obama came into office he made good on his promise to overturn President George W. Bush’s executive order that - with the exception of a handful of existing stem cell lines - prohibited federal funding of human embryonic stem cell (hESC) research.

Advertisement